
No. of Pages: 109 | Report Code: TIPRE00024817 | Category: Life Sciences
No. of Pages: 109 | Report Code: TIPRE00024817 | Category: Life Sciences
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Gastroparesis Market – By Type
1.3.2 Europe Gastroparesis Market – By Drug Class Type
1.3.3 Europe Gastroparesis Market – By Distribution Channel
1.3.4 Europe Gastroparesis Market – By Country
2. Europe Gastroparesis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Gastroparesis Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Europe Gastroparesis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Diabetes Mellitus Prevalence on Rise
5.1.2 Geriatric Population Rising
5.2 Market Restraints
5.2.1 Gastroparesis Drugs Having Side Effects
5.3 Market Opportunities
5.3.1 Rising Financial Assistance for Research
5.4 Future Trends
5.4.1.1 Stress on Gastric Electrical Stimulation Therapy Research
5.5 Impact Analysis
6. Gastroparesis Market – Europe Analysis
6.1 Europe Gastroparesis Market Revenue Forecast and Analysis
7. Europe Gastroparesis Market Analysis – By Type
7.1 Overview
7.2 Europe Gastroparesis Market Revenue Share, by Type (2019 and 2027)
7.3 Idiopathic
7.3.1 Overview
7.3.2 Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Diabetic
7.4.1 Overview
7.4.2 Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Post-Surgical
7.5.1 Overview
7.5.2 Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8. Europe Gastroparesis Market Analysis – By Drug Class Type
8.1 Overview
8.2 Europe Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)
8.3 Prokinetic Agents
8.3.1 Overview
8.3.2 Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Botulinum Toxin Injection
8.4.1 Overview
8.4.2 Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Antiemetic Agents
8.5.1 Overview
8.5.2 Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Gastroparesis Market Analysis – By Distribution Channel
9.1 Overview
9.2 Europe Gastroparesis Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Retail Pharmacies
9.3.1 Overview
9.3.2 Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
10. Europe Gastroparesis Market – Country Analysis
10.1 Overview
10.1.1 Europe: Gastroparesis Market, by Country, 2019 & 2027 (%)
10.1.2 Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.2.1 Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.2.2 Germany Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.2.3 Germany Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.2.4 Germany Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.3 UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 UK Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.3.3 UK Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.3.4 UK Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.4 France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.1 France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.2 France Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.4.3 France Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.4.4 France Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.5 Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.1 Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.2 Spain Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.5.3 Spain Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.5.4 Spain Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.6 Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.2 Italy Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.6.3 Italy Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.6.4 Italy Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.7 Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Rest of Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Rest of Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Rest of Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Gastroparesis Market
11.1 Europe: Impact Assessment Of COVID-19 Pandemic
12. Gastroparesis Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Gastroparesis Market, 2018-2020
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Allergan Plc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bausch Health Companies Inc. (Salix Pharmaceuticals)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Pfizer Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Ipca Laboratories Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Germany Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 3. Germany Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 4. UK Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. UK Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 6. UK Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 7. France Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. France Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 9. France Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 10. Spain Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Spain Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Spain Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 13. Italy Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Italy Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Italy Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 16. Rest of Europe Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Rest of Europe Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Rest of Europe Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 19. Recent Inorganic Growth Strategies in the Gastroparesis market
Table 20. Glossary of Terms, Gastroparesis Market
LIST OF FIGURES
Figure 1. Europe Gastroparesis Market Segmentation
Figure 2. Europe Gastroparesis Market Segmentation, By Country
Figure 3. Europe Gastroparesis Market Overview
Figure 4. Idiopathic Segment Held Largest Share of Europe Gastroparesis Market
Figure 5. Germany to Show Remarkable Growth During Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Europe Gastroparesis Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Gastroparesis Market – Revenue Forecast And Analysis – 2019- 2027
Figure 9. Europe Gastroparesis Market Revenue Share, by Type (2019 and 2027)
Figure 10. Europe Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Europe Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Europe Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Europe Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Europe Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)
Figure 15. Europe Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Europe Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Europe Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Europe Gastroparesis Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 19. Europe Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Europe Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Europe Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Europe: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. Europe: Gastroparesis Market, by Country, 2019 & 2027 (%)
Figure 24. Germany: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. UK: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. France: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Spain: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Italy: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Rest of Europe: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Impact of COVID-19 Pandemic in European Country Markets
Figure 31. Growth Strategies in the Gastroparesis Market, 2018-2020